Generation of lysosomal enzyme variants with enhanced therapeutic potential for the treatment of MPS

Awardee: Alessandro Fraldi

Institution: Telethon Institute of Genetics and Medicine (TIGEM)

Award Amount: $$55,992

Funding Period: February 1, 2019 - January 31, 2020

Previous
Previous

Preclinical studies of FDA-approved small-molecules implementing lysosomal activity in a mouse model of MPSIIIA

Next
Next

Lipidomics biomarkers study of Mucolipidosis IV